Korean J Gastroenterol.  2021 Mar;77(3):97-98. 10.4166/kjg.2021.028.

Prediction of Posthepatectomy Liver Failure by Liver Function Test: Beyond Child Classification

• Heo NY

• KMID: 2514084
• DOI: http://doi.org/10.4166/kjg.2021.028

Reference

1. Korean Liver Cancer Association. National Cancer Center. 2019; 2018 Korean Liver Cancer Association- Korea practice guidelines for the management of hepatocellular carcinoma. Gut Liver. 13:227–299. DOI: 10.5009/gnl19024. PMID: 31060120. PMCID: PMC6529163.

2. Cucchetti A, Ercolani G, Vivarelli M, et al. 2009; Is portal hypertension a contraindication to hepatic resection? Ann Surg. 250:922–928. DOI: 10.1097/SLA.0b013e3181b977a5. PMID: 19855258.

3. Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, Azoulay D. 2016; Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med. 35:49–57. DOI: 10.1016/j.accpm.2015.06.006. PMID: 26477363.

4. Johnson PJ, Berhane S, Kagebayashi C, et al. 2015; Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 33:550–558. DOI: 10.1200/JCO.2014.57.9151. PMID: 25512453. PMCID: PMC4322258.

5. Andreatos N, Amini N, Gani F, et al. 2017; Albumin-bilirubin score: predicting short-term outcomes including bile leak and post-hepatectomy liver failure following hepatic resection. J Gastrointest Surg. 21:238–248. DOI: 10.1007/s11605-016-3246-4. PMID: 27619809.

6. Fagenson AM, Gleeson EM, Pitt HA, Lau KN. 2020; Albumin-bilirubin score vs model for end-stage liver disease in predicting post-hepatectomy outcomes. J Am Coll Surg. 230:637–645. DOI: 10.1016/j.jamcollsurg.2019.12.007. PMID: 31954813.

7. Ruzzenente A, De Angelis M, Conci S, et al. 2019; The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma. Translational Cancer Research. 8:S233–S244. DOI: 10.21037/tcr.2018.12.10.

8. Park HJ, Seo KI, Kim SJ, et al. 2021; Effectiveness of albumin-bilirubin score as a predictor of post-hepatectomy liver failure in patients with hepatocellular carcinoma. Korean J Gastroenterol. 77:115–122. DOI: 10.4166/kjg.2020.148. PMID: 33658474.

9. Mai RY, Wang YY, Bai T, et al. 2019; Combination of ALBI and APRI to predict post-hepatectomy liver failure after liver resection for HBV-related HCC patients. Cancer Manag Res. 11:8799–8806. DOI: 10.2147/CMAR.S213432. PMID: 31632139. PMCID: PMC6779592.

10. Zou H, Wen Y, Yuan K, Miao XY, Xiong L, Liu KJ. 2018; Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients. Liver Int. 38:494–502. DOI: 10.1111/liv.13514. PMID: 28685924.

11. Zhang Z, Ouyang G, Wang P, et al. 2021; Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis. BMC Surg. 21:57. DOI: 10.1186/s12893-021-01065-x. PMID: 33485329. PMCID: PMC7825235.

12. Ge PL, Du SD, Mao YL. 2014; Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int. 13:361–370. DOI: 10.1016/S1499-3872(14)60267-8. PMID: 25100120.